Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.

Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.

We evaluated the adjuvant effect of a modified glycoform of lipopolysaccharide (LPS) (LgtB-LpxL1) compared to that of the nonmodified glycoform Lpxl1 serogroup B meningococcal H44/76 native outer membrane vesicles (nOMVs) on immune responses to vaccination with the recombinant meningococcal protein,...

Full description

Bibliographic Details
Main Authors:	Nagaputra, J, Rollier, C, Sadarangani, M, Hoe, J, Mehta, O, Norheim, G, Saleem, M, Chan, H, Derrick, J, Feavers, I, Pollard, A, Moxon, E
Format:	Journal article
Language:	English
Published:	2014

Similar Items

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on neisseria meningitidis recombinant porA protein: a comparison in mice
by: Mehta, O, et al.
Published: (2014)

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.
by: Ojas H Mehta, et al.
Published: (2014-01-01)

Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine
by: Sadarangani, M, et al.
Published: (2012)

Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.
by: Manish Sadarangani, et al.
Published: (2012-01-01)

Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles.
by: Helene Daniels-Treffandier, et al.
Published: (2016-01-01)

Impact of reducing complement inhibitor binding on the immunogenicity of native neisseria meningitidis outer membrane vesicles
by: Daniels-Treffandier, H, et al.
Published: (2016)

Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
by: Moxon, E, et al.
Published: (1998)

Human B cell responses to dominant and sub-dominant antigens induced by a meningococcal outer membrane vesicle vaccine in a phase I trial
by: Rollier, CS, et al.
Published: (2022)

Application of capillary electrophoresis- electrospray-mass spectrometry to the separation and characterization of isomeric lipopolysaccharides of Neisseria meningitidis.
by: Li, J, et al.
Published: (2004)

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.
by: Marsay, L, et al.
Published: (2015)

Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation
by: Sadarangani, M, et al.
Published: (2016)

Neisseria meningitidis accumulate in large organs during meningococcal sepsis
by: Berit Sletbakk Brusletto, et al.
Published: (2023-11-01)

Primary Meningococcal Arthritis Leading to Neisseria Meningitidies Purpura Fulminans
by: Michael D. Michel, et al.
Published: (2013-03-01)

Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B
by: Rivero-Calle I, et al.
Published: (2019-10-01)

Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial
by: Chang, C-M, et al.
Published: (2022)

PorA Variable Regions of Neisseria meningitidis
by: Joanne E. Russell, et al.
Published: (2004-04-01)

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis
by: Awanye, A, et al.
Published: (2019)

Structural and genetic characterisation of variant glycoforms of Haemophilus influenzae lipopolysaccharide; implications for virulence
by: Schweda, E, et al.
Published: (2010)

lpt6, a gene required for addition of phosphoethanolamine to inner-core lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae.
by: Wright, J, et al.
Published: (2004)

FetA antibodies induced by an outer membrane vesicle vaccine derived from a serogroup B meningococcal isolate with constitutive FetA expression
by: Sanders, H, et al.
Published: (2015)

Rare generalized form of meningococcal disease caused by Neisseria meningitidis serogroup W
by: L. N. Mazankova, et al.
Published: (2020-03-01)

Meningococcal C Disease Outbreak Caused by Multidrug-Resistant Neisseria meningitidis, Fiji
by: Aneley Getahun Strobel, et al.
Published: (2025-01-01)

The genetic characteristics of Neisseria meningitidis causing invasive meningococcal infections in Smolensk region
by: Mironov K.O., et al.
Published: (2020-05-01)

Genetic Variation in Neisseria meningitidis Does Not Influence Disease Severity in Meningococcal Meningitis
by: Philip H. C. Kremer, et al.
Published: (2020-11-01)

Correlates of protection against Neisseria Meningitidis.
by: Pollard, A
Published: (2016)

Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis.
by: Alcides Moniz Munguambe, et al.
Published: (2018-01-01)

An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential
by: Stork, M, et al.
Published: (2010)

An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential.
by: Stork, M, et al.
Published: (2010)

Enfermedad por meningococo, Neisseria meningitidis: perspectiva epidemiológica, clínica y preventiva Meningococcal disease caused by Neisseria meningitidis: epidemiological, clinical, and preventive perspectives
by: Lourdes Almeida-González, et al.
Published: (2004-10-01)

Rapid and fatal meningococcal disease due to a strain of Neisseria meningitidis containing the capsule null locus.
by: Hoang, L, et al.
Published: (2005)

Development of natural immunity to Neisseria meningitidis.
by: Pollard, A, et al.
Published: (2001)

Functional significance of factor H binding to Neisseria meningitidis.
by: Schneider, M, et al.
Published: (2006)

Direct detection and serogroup characterization of Neisseria meningitidis from outbreak of meningococcal meningitis in Delhi
by: SS Negi, et al.
Published: (2010-06-01)

Invasive meningococcal disease epidemiology and characterization of Neisseria meningitidis serogroups, sequence types, and clones; implication for use of meningococcal vaccines
by: Chen Stein-Zamir, et al.
Published: (2019-01-01)

First case of interconnected clusters of primary meningococcal arthritis and meningococcal meningitis due to Neisseria meningitidis serogroup B in Slovenia
by: Miha Simoniti, et al.
Published: (2021-06-01)

Description and nomenclature of Neisseria meningitidis capsule locus
by: Harrison, O, et al.
Published: (2013)

FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.
by: Holly Sanders, et al.
Published: (2015-01-01)

Obstetric and Neonatal Invasive Meningococcal Disease Caused by Neisseria meningitidis Serogroup W, Western Australia, Australia
by: Julie Hart, et al.
Published: (2024-02-01)

Crystal structure of outer membrane protein NMB0315 from Neisseria meningitidis.
by: Xiangyu Wang, et al.
Published: (2011-01-01)

An outer membrane receptor of Neisseria meningitidis involved in zinc acquisition with vaccine potential.
by: Michiel Stork, et al.
Published: (2010-01-01)